Announcements Trials
Browse Landscape

Phase

Phase 2 26Phase 1 20Phase NA 12Phase 1/2 8Phase EARLY_PHASE1 5Phase 3 3Phase 2/3 2Phase 4 1

Status

Completed 26Recruiting 16Terminated 14Unknown 9Active not recruiting 8Withdrawn 5Not yet recruiting 4

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

CNS 5Sarcoma 1

Conditions

Breast Neoplasms 16Neoplasms 11Pancreatic Neoplasms 10Prostatic Neoplasms 7Glioma 6Squamous Cell Carcinoma of Head and Neck 5Ovarian Neoplasms 5Head and Neck Neoplasms 5Glioblastoma 5Carcinoma, Non-Small-Cell Lung 5Triple Negative Breast Neoplasms 4Sarcoma 4Polycystic Ovary Syndrome 4Colonic Neoplasms 4Obesity 3Neoplasm Metastasis 3Multiple Myeloma 3Melanoma 3Lymphoma 3Lung Neoplasms 3Carcinoma, Intraductal, Noninfiltrating 3Brain Neoplasms 3Pain, Postoperative 2Fallopian Tube Neoplasms 2Esophageal Neoplasms 2Endometrial Neoplasms 2Depression 2Cholangiocarcinoma 2Central Nervous System Neoplasms 2Carcinoma, Renal Cell 2

Interventions

fluciclovine F-18 1Triiodothyronine 1Standard of Care 1Methimazole 1Lomustine 1Carvedilol 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Withdrawn × Glioblastoma × Clear all
NCT05054400 2023-09-01

Study of Laser Interstitial Thermal Therapy (LITT) Treatment Response Assessment With Fluciclovine PET MR

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Withdrawn
CNS

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms

NCT05017610 2022-12-02

Inducing a Hypothyroxinemic State in Patients With Recurrent Glioblastoma or Gliosarcoma

Emory University

Phase EARLY_PHASE1 Withdrawn
CNSSarcoma

Glioblastoma, Gliosarcoma

NCT04776980 2022-09-16

Multimodality MRI and Liquid Biopsy in GBM

Abramson Cancer Center at Penn Medicine

Phase EARLY_PHASE1 Withdrawn
CNS

Brain Neoplasms, Glioblastoma

NCT01331616 2021-12-09

Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab

West Penn Allegheny Health System

Phase EARLY_PHASE1 Withdrawn
CNS

Glioblastoma, Optic Nerve Diseases

NCT03980249 2021-04-12

Anti-Cancer Effects of Carvedilol With Standard Treatment in Glioblastoma and Response of Peripheral Glioma Circulating Tumor Cells

West Virginia University

Phase EARLY_PHASE1 Withdrawn
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡